The Insightful Corner Hub: Bridging the Gap: A Comparative Analysis of African Community Pharmacists' Scope of Practice in Contrast with Global Models

Introduction: The World's Most Accessible Clinicians

In the sprawling urban neighborhoods of Lagos, the trading posts of rural Ghana, and the dusty townships of South Africa, there exists a healthcare professional who requires no appointment, charges no consultation fee, and remains open when hospitals have long closed their doors. They know their patients by name, understand family histories, and have earned the trust of communities over decades of service.

They are community pharmacists, and across Africa, they represent the most accessible point of entry into the formal health system. Recent data from Nigeria reveals that nearly 60 percent of patients seek advice from pharmacists before visiting hospitals . This statistic, emerging from stakeholder consultations in early 2026, confirms what health systems researchers have long suspected: the neighborhood pharmacy is often the first, and sometimes only, contact between citizens and professional healthcare.

Yet despite this proximity and trust, a profound gap exists between what African community pharmacists are permitted to do and what their counterparts in high-income countries now practice as routine. While pharmacists in the United Kingdom prepare to make all newly qualified graduates independent prescribers from September 2026 , and while Canadian "Pharmacy Care Clinics" offer everything from minor ailment treatment to chronic disease management , African pharmacists largely remain constrained to dispensing roles defined by regulations written decades ago.

This article offers a comprehensive comparative analysis of community pharmacists' scope of practice across selected African countries—with particular attention to Nigeria, Ghana, and South Africa—in contrast with global models from the United Kingdom, Canada, the United States, and Australia. Drawing on systematic reviews, policy documents, and recent professional initiatives from 2025-2026, it examines the gaps, identifies emerging frameworks for bridging them, and charts a path toward the full integration of pharmacists into primary healthcare systems.

Part One: Defining the Scope of Practice

What Constitutes "Full Scope"?

Before comparing scope across jurisdictions, we must establish what "full scope of practice" means for community pharmacists. A landmark systematic review published in Pharmacy in November 2025, conducted by Clemens and colleagues and registered with PROSPERO (CRD42025626045), provides the most comprehensive framework to date .

The review analyzed 23 international studies and identified four thematic clusters essential to understanding pharmacist prescribing and expanded practice: (1) expanding clinical and public health roles and pharmacists' self-perceived readiness; (2) regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions; (3) inferred competencies, including micro-skills (patient assessment, guideline application) and macro-capabilities (clinical judgment, accountability, reflective practice); and (4) contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges .

Critically, the review concluded that "pharmacist prescribing is safe and patient-centered when supported by regulation, structured training, and systemic integration" . This finding undercuts arguments that expanded authority inherently compromises safety, instead emphasizing that safety depends on the systems surrounding practice.

The core elements of expanded scope, drawn from international models, include:

Independent Prescribing Authority: The ability to prescribe medications autonomously, without requiring a physician's signature or pre-approved protocol. This ranges from prescribing for minor ailments to managing chronic conditions like hypertension and diabetes.

Prescription Adaptation: Authority to modify the formulation, regimen, duration, or route of administration of existing prescriptions based on clinical judgment and patient needs .

Minor Ailment Management: Formal programs allowing pharmacists to assess patients presenting with common conditions (e.g., urinary tract infections, allergic rhinitis, uncomplicated skin conditions) and supply medications when appropriate.

Chronic Disease Management: Ongoing responsibility for patients with stable chronic conditions, including monitoring, medication adjustment, and lifestyle counseling. The UK's NHS has explicitly committed to increasing pharmacists' role in "management of long-term conditions, complex medication regimes, and treatment of obesity, high blood pressure and high cholesterol" .

Point-of-Care Testing and Diagnostic Services: Performing and interpreting rapid diagnostic tests—for malaria, blood glucose, cholesterol, and other conditions—to enable immediate clinical decision-making.

Vaccination and Preventive Services: Administering routine and catch-up immunizations. The UK plans to enable pharmacists to provide human papillomavirus (HPV) vaccinations from 2026 to those who missed school-based programs .

Health System Integration: Secure connection to patient records, enabling seamless information sharing with general practitioners and other providers .

The Competency Foundation

Expanded scope requires corresponding competencies. The systematic review distinguishes between micro-skills—patient assessment, application of clinical guidelines—and macro-capabilities such as clinical judgment, accountability, and reflective practice . These cannot be assumed; they must be developed through structured training, supervised practice, and continuing professional development.

A 2024 Master's dissertation from the University of Malta examined competency frameworks internationally, identifying the International Pharmaceutical Federation's Global Competency Framework (GbCF) as the foundational reference . The research found that while frameworks share core domains, distinctions emerge in "the design of updated user-friendly versions, of culturally related and new emerging domains reflecting the evolving nature of the profession" .

This finding has particular relevance for Africa, where competency frameworks must reflect local disease burdens, health system structures, and cultural contexts while maintaining alignment with global standards.

Part Two: Global Models of Advanced Practice

United Kingdom: The Independent Prescribing Frontier

The United Kingdom represents perhaps the most advanced model of pharmacist prescribing globally. From September 2026, all newly qualified pharmacists in England will register as independent prescribers . This represents a fundamental shift in professional identity—from dispensers to clinicians as the default.

The Department of Health and Social Care has been explicit about the transformation: "Over the next five years, we will transition community pharmacy from being focused largely on dispensing medicines to becoming integral to the Neighbourhood Health Service, offering more clinical services" .

This transition encompasses multiple dimensions. Pharmacists will increase their role in managing long-term conditions, with specific focus on hypertension, high cholesterol, and obesity. They will expand preventive services, including cardiovascular screening and diabetes risk assessment. And they will be "securely joined up to the Single Patient Record, to help them provide a seamless service—and to give GPs sight of patient management" .

The UK model also emphasizes women's health, with emergency hormonal contraception made freely available from community pharmacists by the end of 2025 and HPV vaccination from 2026 . This integration of pharmacy into national public health priorities demonstrates how expanded scope can serve broader policy objectives.

Canada: Pharmacy Care Clinics and Provincial Innovation

Canada offers a decentralized model, with provinces independently determining pharmacists' authority. The concept of "Pharmacy Care Clinics" has emerged as a framework for comprehensive community pharmacy services, providing "support with minor ailments through to chronic disease management" .

The Canadian approach includes prescription adaptation authority, allowing pharmacists to modify regimens, durations, and routes of administration . This flexibility enables pharmacists to respond to supply chain disruptions, patient intolerances, and other clinical situations without requiring new physician consultations.

The UK government has explicitly cited Canada as a model, noting that "there is now strong evidence that a bigger role for pharmacy can deliver efficiencies and support financial sustainability" .

United States: State-Led Expansion

The United States has seen uneven but significant expansion of pharmacist authority, driven primarily by state legislation. Washington State's Substitute Senate Bill 5924, passed in 2026, exemplifies the direction of travel, explicitly expanding the legal definition of pharmacy practice to include "limited diagnosing" and "prescribing or ordering of drugs and devices" .

The systematic review notes that the US, like Canada, has implemented pharmacist prescribing, though frameworks vary substantially by state . Pandemic-related temporary exemptions in many jurisdictions demonstrated the feasibility of expanded authority and have informed permanent reforms.

Australia: Structured Prescribing Pathways

Australia has pursued structured expansion, with South Australia's Regulation 17A of the Controlled Substances (Poisons) Regulations 2011 authorizing authorized pharmacists to prescribe certain Schedule 4 medicines . The accompanying Community Pharmacist Prescribing Code specifies training requirements, clinical practice guidelines, and conditions for prescribing, creating a transparent and accountable framework.

This layered approach—statute, regulation, code, and register—provides a template for jurisdictions seeking to expand scope while maintaining safeguards.

Common Elements of Success

Across these diverse models, common elements emerge. Each jurisdiction has established clear regulatory frameworks defining authority and qualifications. Each has invested in training and competency development. Each has created mechanisms for integration with broader health systems, including shared records and referral pathways. And each has developed sustainable funding models, whether through public commissioning (UK), insurance reimbursement (Canada), or mixed approaches.

The systematic review's synthesis of implementation implications captures these essentials: "training, funding, acceptance, and integration" . None is optional; all must be addressed for expanded scope to succeed.

Part Three: The African Landscape

Nigeria: The Most Accessible Yet Constrained

Nigeria offers the most detailed picture of community pharmacy practice in Africa, thanks to recent professional initiatives and stakeholder engagements. The Association of Community Pharmacists of Nigeria (ACPN) has been explicit about both the potential and the constraints.

In January 2026, the ACPN reaffirmed that community pharmacies are "legally recognised health facilities" in Nigeria, responding to public debate about the scope of pharmacy practice . The association cited the National Health Act of 2014, emphasizing that pharmacies "form an integral part of Nigeria's healthcare delivery system" .

The ACPN highlighted that point-of-care testing—particularly rapid diagnostic tests for malaria—is "encouraged by the Federal Ministry of Health as part of national disease control strategies" . This alignment with national policy is significant: confirming malaria infection before dispensing antimalarial medicines "helps to prevent drug misuse and resistance" .

However, the association also acknowledged boundaries. Community pharmacies "without registered laboratory units are expected to comply strictly with existing laws and professional guidelines" . The integration of retail sections within some pharmacies follows "an internationally accepted model designed to improve patient convenience," with similar approaches existing "in the United Kingdom, the United States, and other advanced health systems" .

The most significant development in Nigerian pharmacy practice emerged from a March 2026 stakeholder engagement in Abuja, organized by the ACPN and the Community Pharmacists Assessment and Career Progression Institute (CPACPI) .

The CPACPI framework introduces a five-level professional progression ladder:

Community Pharmacist
Senior Community Pharmacist
Community Pharmacy Specialist
Community Pharmacy Senior Specialist
Community Pharmacy Consultant

This structure links career advancement with "measurable clinical outcomes, mentorship and regular professional appraisal, helping to improve service quality and strengthen the health workforce" . The framework has already gained international recognition, having been presented at the global congress of the International Pharmaceutical Federation in Copenhagen, where it was described as "an innovative model for advancing pharmacy practice" .

ACPN National Chairman Ambrose Ezeh captured the vision: "Community pharmacists remain the most accessible healthcare professionals in the country" . The CPACPI framework aims to "evaluate, support and strengthen community pharmacy practice through a structured career progression system," rewarding competence and "improving professional confidence among pharmacists working in private practice" .

Yet the call for government support underscores remaining barriers. Participants urged "legislators to provide the necessary institutional backing" and called on "pharmacy owners and individual community pharmacists nationwide to enroll in the CPACPI programme" .

Ghana: Expanding Access Through SEAPS

Ghana's Pharmaceutical Society (PSGH) has pursued expanded access through its Strategy to Enhance Access to Pharmaceutical Services (SEAPS) project. In December 2025, selected pharmacists received support to establish practices in underserved and deprived communities .

PSGH President Pharm. Paul Owusu Donkor emphasized "the critical role of community pharmacies in healthcare delivery, while acknowledging the significant challenges they face, including supply chain constraints, limited access to finance, cash flow difficulties, data and inventory management gaps, and regulatory compliance requirements" .

The SEAPS project addresses these barriers through collaboration with "AdvancePharma Innovations, pharmaceutical suppliers, financial institutions, and notably the Ghana Cooperative Pharmacists Credit Union Ltd" to facilitate "flexible and hassle-free access to funding" .

This focus on the business dimension of pharmacy practice—recognizing that "passion for helping people will take you far as a pharmacist, but on its own, it will not keep the doors open" —represents an essential complement to clinical scope expansion.

South Africa: Independent Pharmacies and Community Hubs

South Africa's pharmacy sector is notable for its independence. By 2021, approximately 3,580 community pharmacies operated across the country, with "nearly 70% of these were independent rather than corporate-owned"—over 2,000 small businesses "carrying community healthcare" .

This independent sector faces distinctive challenges: "juggling supplier deliveries, unpredictable supply chain issues, negotiating credit terms, paying staff, and trying to keep overheads under control" . Yet the potential for expanded scope is substantial, given "the country's high and rising burden of chronic disease" including "diabetes, hypertension, and HIV" .

Industry analysis suggests that pharmacies are "no longer limited to handing out prescriptions." According to Deloitte, "many pharmacies are transforming into community health hubs by adding point-of-care testing, preventative health screening, and digital services to meet the changing expectations of modern consumers" .

The South African experience highlights that "independent outlets do more than only dispense medicine, they also cut travel time, keep treatment within reach, and help build local economies" . This community economic development dimension is often overlooked in clinical discussions but essential to sustainability.

The Interprofessional Dimension

A 2022 poster presented at the International Pharmaceutical Federation conference examined interprofessional collaboration (IPC) across countries with varying development levels . The research, which compared pharmacy professional standards in "very high" Human Development Index (HDI) countries (Australia, Hong Kong, Canada, United Kingdom) with "low" HDI countries (Solomon Islands, Haiti, Yemen, South Sudan), found that "only HDI-classified 'very high' had professional standards' documents, frequently incorporating IPC" .

Key IPC themes included "shared decision-making," "continuity-of-care," and "effective communication." Studies confirmed IPC benefits: "fewer medication-related errors" . The number of IPC standards and HDI rank for 'very high' countries "were positively correlated, suggesting possible economic impact on pharmacy sector progress" .

While this research did not include African countries, its implications are clear: professional standards and interprofessional collaboration are associated with development levels. Bridging the gap requires not only clinical scope expansion but also the regulatory and standards infrastructure that enables effective collaboration.

The Common Constraints

Across these African examples, common constraints emerge:

Regulatory Limitations: No African country currently authorizes independent pharmacist prescribing comparable to the UK or Canadian models. While point-of-care testing is encouraged in some contexts (e.g., malaria RDTs in Nigeria) , this falls far short of comprehensive clinical authority.

Competency Gaps: The CPACPI framework explicitly addresses "the lack of a standardised competency framework" that has "historically limited the impact of community pharmacists" . Structured career progression tied to measurable outcomes represents an essential foundation.

Business Sustainability: Pharmacies are businesses, and expanded clinical services require viable business models. Ghana's SEAPS project addresses "limited access to finance, cash flow difficulties" , while South African analysis emphasizes that "independent pharmacies need to be run with the same discipline as any other retailer" .

Health System Integration: Connection to national health information systems, referral pathways, and collaborative relationships with other providers remain underdeveloped. The UK's commitment to connecting pharmacies to the "Single Patient Record" represents an aspiration still distant for most African contexts.

Acceptance: Both professional acceptance (pharmacists' confidence in expanded roles) and public acceptance (patients' willingness to receive care from pharmacists) require cultivation. The CPACPI framework's emphasis on "improving professional confidence among pharmacists working in private practice" addresses the former; patient education and experience will address the latter.

Part Four: Comparative Analysis

To make the comparison concrete, the following table synthesizes scope elements across selected African countries and global comparators:

Scope Element	Nigeria (Current)	Ghana (Current)	South Africa (Current)	United Kingdom (2026)	Canada	United States (Leading States)	Australia (South Australia)
Independent Prescribing	Not authorized	Not authorized	Not authorized	Full for all newly qualified pharmacists (from 2026)	Provincial, expanding	Limited, state-dependent	Limited (Schedule 4 medicines)
Prescription Adaptation	Not authorized	Not authorized	Limited	Authorized	Authorized (dose, duration, formulation)	State-dependent	Authorized under protocols
Minor Ailment Management	Informal	Informal	Informal	Formal national programs (e.g., Pharmacy First)	Formal programs	Expanding	Emerging
Chronic Disease Management	Informal	Informal	Informal	Formal services (hypertension, lipids, obesity)	Provincial programs	Expanding (e.g., diabetes, hypertension)	Emerging
Point-of-Care Testing (POCT)	Malaria RDTs encouraged	Limited	Emerging	Expanding	Common	Expanding	Expanding
Vaccination Services	Limited	Limited	Limited	Routine (including HPV from 2026)	Routine	Routine	Routine
Diagnostic Authority	Limited (mainly RDTs)	None	None	Limited (linked to prescribing)	Limited	Limited diagnosing authority (e.g., Washington State)	Not clearly defined
Formal Health System Recognition	Recognized as health facility	Recognized	Recognized	Fully integrated (NHS)	Integrated at provincial level	State-dependent integration	Recognized
Reimbursement for Clinical Services	Minimal	Minimal	Minimal	NHS-funded services	Available in some provinces	Emerging (insurance-based)	Available in some programs
Structured Competency Framework	CPACPI framework (emerging)	SEAPS-supported framework	Emerging	Established (GPhC standards)	Provincial competency frameworks	State board frameworks	Established (Prescribing Code)
Connection to Patient Records	No	No	No	Integrated Single Patient Record system	Provincial electronic systems	Emerging (EHR integration)	Emerging

Analysis of the Gap

This comparison reveals a gap that is not incremental but fundamental. In every dimension of expanded practice—prescribing, adaptation, chronic disease management, diagnostic authority—African pharmacists operate with a fraction of the authority granted to their counterparts in leading jurisdictions.

The gap is widest in independent prescribing. The UK's decision to make all new pharmacists independent prescribers from 2026 represents a paradigm shift that has no parallel in Africa. While Nigeria's CPACPI framework establishes career progression, it does not yet confer prescribing authority at any level.

The gap narrows somewhat in point-of-care testing, where Nigeria's encouragement of malaria RDTs aligns with global trends. Yet even here, the scope is limited to a single test for a single condition, whereas pharmacies in high-income countries increasingly offer comprehensive screening panels.

The gap in health system integration is particularly concerning. Without connection to patient records, referral pathways, and information sharing mechanisms, even expanded authority would operate in isolation—potentially fragmenting care rather than strengthening systems.

Explaining the Gap

Why does this gap persist? The systematic review's identification of "contextual barriers such as training gaps, limited funding, unclear legal provisions, and workflow challenges" applies with particular force to Africa.

Training Gaps: Pharmacy curricula across much of Africa remain focused on pharmaceutical sciences rather than clinical practice. The competencies required for prescribing—patient assessment, clinical reasoning, diagnostic interpretation—are not systematically developed.

Regulatory Frameworks: Pharmacy laws in most African countries predate the modern conception of pharmacists' clinical role. Amending these frameworks requires legislative action, which proceeds slowly and competes with other priorities.

Funding Constraints: Expanded clinical services require sustainable financing. In health systems where public funding is severely constrained and insurance coverage limited, reimbursement mechanisms for pharmacy services are underdeveloped.

Interprofessional Dynamics: Physician resistance to expanded pharmacy scope is documented globally but may be particularly entrenched where physician density is low and professional boundaries strongly defended. The Nigerian ACPN's response to medical laboratory scientists' concerns about diagnostic activities illustrates these tensions.

Health System Priorities: African health systems face competing urgent priorities—HIV, malaria, maternal mortality, emerging infectious diseases. Pharmacy scope expansion, while potentially transformative, may appear less pressing than immediate life-saving interventions.

Part Five: Bridging the Gap

The CPACPI Framework: A Template for Competency Development

Nigeria's CPACPI framework represents the most developed African initiative to bridge the competency gap. Its five-level progression ladder—from Community Pharmacist to Community Pharmacy Consultant—creates structured pathways for professional development tied to "measurable clinical outcomes, mentorship and regular professional appraisal" .

The framework's international recognition at the FIP global congress in Copenhagen suggests that it aligns with global standards while being adapted to Nigerian realities. This is precisely the approach the Malta dissertation identified as essential: frameworks that share core domains while incorporating "culturally related and new emerging domains reflecting the evolving nature of the profession" .

For other African countries, the CPACPI model offers a template that can be adapted rather than reinvented. Key elements include:

Structured progression linked to demonstrated competence
Mentorship and regular appraisal
Recognition of achievement through professional titles
Alignment with national health priorities
Engagement with government and regulatory bodies

The SEAPS Model: Addressing Business Sustainability

Ghana's SEAPS project addresses a dimension often overlooked in clinical discussions: business viability. By facilitating "flexible and hassle-free access to funding" , SEAPS enables pharmacists to establish and sustain practices in underserved areas where patient volume may be insufficient to generate immediate profits.

The recognition that pharmacies are businesses—and that "passion for helping people will take you far as a pharmacist, but on its own, it will not keep the doors open" —is essential for sustainability. Expanded clinical services require investment in equipment, training, and sometimes facility modifications. Without access to capital, even willing pharmacists cannot expand their scope.

The Ghanaian approach of collaborating with financial institutions, including the "Ghana Cooperative Pharmacists Credit Union Ltd" , offers a replicable model. Pharmacy-owned financial cooperatives understand the profession's needs and can offer tailored products that commercial banks may not provide.

Regulatory Reform: The Foundation

Neither competency frameworks nor business support can succeed without regulatory reform. The systematic review's emphasis on "regulatory frameworks defining legal authority, qualifications, and temporary pandemic exemptions" underscores that expanded scope must be legally authorized before it can be practiced.

Regulatory reform in African contexts should consider:

Layered Authority: Following the Australian model of statute, regulation, code, and register , African countries can create frameworks that authorize expanded practice while maintaining safeguards.

Phased Implementation: Rather than attempting comprehensive reform immediately, countries might begin with specific authorizations—minor ailment prescribing, chronic disease management for specific conditions—and expand based on experience.

Competency-Based Authorization: Authority should be tied to demonstrated competence, not merely licensure. The CPACPI framework's progression ladder could serve as the basis for tiered authorization, with higher levels of practice conferring greater authority.

Public Register: As in South Australia, a public register of authorized pharmacists enables verification of credentials and prescription authenticity , supporting accountability.

Health System Integration

Expanded pharmacy practice cannot succeed in isolation. The UK's commitment to connecting pharmacies to the "Single Patient Record" reflects the principle that patients should not have to manage fragmented information across multiple providers.

For African health systems, integration requires:

Digital Infrastructure: Investment in health information systems that include pharmacies. Nigeria's stakeholders discussed "improving service data reporting to the national health information system" —a critical first step.

Referral Pathways: Clear protocols for when pharmacists should refer patients to other providers, and mechanisms for ensuring referred patients are received.

Shared Care Agreements: Formal agreements between pharmacists and physicians defining responsibilities for shared patients, particularly those with chronic conditions.

Interprofessional Education: Training pharmacists and other health professionals together, building understanding of roles and relationships before they enter practice.

Sustainable Financing

Clinical services require funding. Options for African contexts include:

Public Commissioning: As in the UK's NHS model, governments could commission specific pharmacy services—hypertension management, malaria testing and treatment—as part of public health programs.

Insurance Reimbursement: Where social health insurance exists, pharmacy services could be included in benefit packages. Where it does not, community-based health insurance schemes might cover pharmacy services.

Appropriate User Fees: For services not otherwise funded, regulated user fees with exemptions for vulnerable populations can sustain services while maintaining access.

Cross-Subsidization: As in the "retail" sections of Nigerian pharmacies , commercial activities can cross-subsidize clinical services—a model that requires careful management to maintain professional focus.

Learning from Successes

Several African initiatives offer lessons for broader application:

Nigeria's Malaria RDT Program: The Federal Ministry of Health's encouragement of pharmacy-based malaria testing demonstrates how national disease control strategies can integrate pharmacy services. This model could extend to other conditions—HIV self-testing, hypertension screening, diabetes risk assessment.

Ghana's SEAPS Project: The focus on financing and business support addresses the sustainability challenge directly. Similar initiatives in other countries could accelerate pharmacy expansion into underserved areas.

South Africa's Independent Sector: The predominance of independent pharmacies offers opportunities for community-embedded practice that corporate models may not provide. Supporting independents through business training and access to capital could preserve this diversity while expanding scope.

CPACPI's Competency Framework: The five-level progression provides a template that other countries can adapt, accelerating framework development and maintaining alignment with global standards.

Part Six: A Roadmap for Implementation

Phase 1: Foundation (Years 1-3)

Regulatory Review and Reform: Conduct comprehensive review of pharmacy laws to identify barriers. Develop amendments authorizing structured scope expansion, with clear authority tied to demonstrated competence.

Competency Framework Development: Adapt CPACPI model or similar frameworks to national contexts. Define competencies required for each level of practice. Develop assessment mechanisms.

Stakeholder Engagement: Engage government, regulators, professional associations, other health professions, and patient groups. Build consensus on vision and approach. Learn from Nigeria's stakeholder engagement model .

Business Support Infrastructure: Following Ghana's SEAPS example , develop mechanisms for pharmacy access to capital, particularly for underserved areas.

Phase 2: Piloting and Learning (Years 2-5)

Pilot Programs: Test expanded scope in selected pharmacies—perhaps beginning with minor ailment management or hypertension monitoring. Generate evidence on feasibility, safety, and impact.

Training Scale-Up: Integrate expanded competencies into pre-service curricula. Develop continuing professional development for practicing pharmacists.

Reimbursement Pilots: Test financing mechanisms—public commissioning, insurance reimbursement, appropriate fees—in pilot sites.

Integration Development: Build digital infrastructure for pharmacy connection to health information systems. Develop referral protocols and shared care agreements.

Phase 3: Scale-Up and System Integration (Years 4-8)

Regulatory Implementation: Implement regulatory reforms authorizing expanded practice beyond pilots. Establish registration systems for authorized pharmacists.

National Roll-Out: Expand successful approaches nationally, with attention to geographic equity and support for underserved areas.

Sustainable Financing: Establish permanent reimbursement mechanisms for clinical services. Integrate pharmacy services into health financing frameworks.

Full Health System Integration: Connect pharmacies to national health information systems. Embed pharmacists in referral networks and primary care teams.

Phase 4: Advanced Practice (Years 7-10)

Independent Prescribing: For pharmacists achieving highest competency levels, authorize independent prescribing for defined conditions.

Specialization Pathways: Develop advanced practice pathways in areas like chronic disease management, HIV care, mental health, and women's health.

Regional Harmonization: Work toward regional recognition of credentials and competencies, facilitating mobility and mutual learning.

Research and Innovation: Establish research programs evaluating impact and identifying innovations. Contribute to global evidence base on pharmacy practice in LMICs.

Conclusion: From Dispensers to Clinicians

The community pharmacist in Africa stands at a threshold. Behind lies the traditional role—dispensing medications according to prescriptions written by others, affixing labels, collecting payments. Ahead lies a transformed profession—assessing patients, managing chronic disease, prescribing treatments, and serving as an integrated member of primary care teams.

The distance between these two visions is not measured in kilometers but in policy decisions, regulatory reforms, and investments in people and systems. It is a distance that pharmacists in the United Kingdom, Canada, Australia, and parts of the United States have traversed—not overnight, and not without challenges, but steadily and successfully.

The evidence that this journey is worth taking is now overwhelming. Systematic reviews confirm that pharmacist prescribing is safe and patient-centered when properly supported . Implementation experience demonstrates that expanded pharmacy services improve access, reduce burden on overstretched systems, and achieve high patient satisfaction . The UK's commitment to making all new pharmacists independent prescribers reflects confidence that this is not merely an option but the future of the profession.

For Africa, the urgency is compounded by context. Health systems are strained beyond capacity. Non-communicable diseases are rising alongside persistent infectious burdens. Health worker shortages show no sign of resolving. In this context, leaving the most accessible health professionals practicing at a fraction of their potential is a luxury the continent cannot afford.

The Nigerian pharmacists who gathered in Abuja in March 2026 understood this urgency. Their call for government support to "turn community pharmacies into key healthcare hubs capable of delivering a wider range of primary healthcare services" echoes across the continent. The CPACPI framework they developed, with its five-level career progression and international recognition, demonstrates that African pharmacists are not waiting for change but working to create it.

The Ghanaian pharmacists launching practices in underserved communities through SEAPS are demonstrating what is possible when business support meets professional commitment. The South African independents serving as "cornerstones of their communities" are proving that pharmacies can be both clinically excellent and economically viable.

What remains is for governments, regulators, educators, and development partners to join them. To provide the policy support, regulatory reform, investment in training, and sustainable financing that expanded practice requires. To recognize that the pharmacy on the corner is not just a place to buy medicine but a healthcare facility waiting to be activated.

The pharmacist behind the counter is not just a dispenser but a clinician. It is time to bridge the gap and let them practice as one.

References

Association of Community Pharmacists of Nigeria. (2026, January 13). Community pharmacies are recognised health facilities, ACPN insists. Vanguard News.
Clemens, S., Eisl-Raudaschl, L., Pachmayr, J., & Rose, O. (2025). Community Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications. Pharmacy, 13(6), 157.
Fazaa, M. (2024). Certification and competency frameworks (Master's dissertation). University of Malta.
Pharmaceutical Society of Ghana. (2025, December 15). PSGH supports pharmacists to establish practices in underserved communities under SEAPS Project. Ghana Pharmaceutical Journal.
New Telegraph. (2026, March 12). Pharmacists Push For Nat'l Support To Turn Community Pharmacies Into Healthcare Hubs.
Pharmacy Business. (2025, July 3). Independent prescribing will lead to pharmacy 'transitioning' from dispensing to clinical services.
Dar, A., & Jones, S.C. (2022). Interprofessional Collaboration (IPC): A Comparative Analysis of Global Standards for Pharmacy Practice. Poster presented at FIP PPR 2022.
African News Agency. (2025, September 17). The future of pharmacies in South Africa lies in sustainable expansion.
The Sun Nigeria. (2026, March 11). Stakeholders endorse new framework for community pharmacy practice.
Clemens, S., Eisl-Raudaschl, L., Pachmayr, J., & Rose, O. (2025). Community Pharmacist Prescribing: Roles and Competencies—A Systematic Review and Implications. Pharmacy, 13(6), 157. [PMCID: PMC12641902]

Related:

Conclusion

While African community pharmacists play a vital role in healthcare, there is an opportunity to enhance their scope of practice to align with global standards. Addressing regulatory, educational, and public awareness challenges is essential for empowering African community pharmacists and maximizing their contributions to public health.

References:

American Pharmacists Association. (2017). Scope of practice for pharmacists. https://www.pharmacist.com/scope-practice-pharmacists
Bukama, M. C., Kandolo, S. K., & Palleria, C. (2020). Community pharmacy practice in Africa: Challenges and opportunities. Pharmacy Practice, 18(2), 1868. https://doi.org/10.18549/PharmPract.2020.2.1868
Canadian Pharmacists Association. (2017). Professional services provided by pharmacists in community pharmacies. https://www.pharmacists.ca/pharmacy-in-canada/about-pharmacy-in-canada/professional-services/
National Health Service. (2021). Community pharmacy contractual framework for England. https://www.england.nhs.uk/nhs-standard-contract/comm-pharm/
Ordre National des Pharmaciens. (2021). Professional practice in pharmacy. https://www.ordre.pharmacien.fr/Les-guides/Professional-practice-in-pharmacy
Oparah, A. C. (2011). The role of the pharmacist in public health: A survey of community pharmacists in Nigeria. Journal of Pharmacy Practice and Research, 41(3), 222–224. https://doi.org/10.1002/j.2055-2335.2011.tb00620.x
Pharmaceutical Society of Australia. (2021). Community pharmacy. https://www.psa.org.au/practice-support/community-pharmacy/
Suleman, S., & Khatib, R. (2012). The changing roles of pharmacists in community settings: Perception of a sample of non-health professionals in Pakistan. Journal of Young Pharmacists, 4(3), 169–176. https://doi.org/10.4103/0975-1483.100937

Translate